Skip Navigation



Annals of Oncology Advance Access published online on September 16, 2009
Annals of Oncology, doi:10.1093/annonc/mdp344
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lee, J. S.
Right arrow Articles by Park, H. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. S.
Right arrow Articles by Park, H. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

Metabolic syndrome and cancer-related mortality among Korean men and women

J. S. Lee1, S.-I. Cho2 and H. S. Park1,*

1 Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine
2 Department of Epidemiology, School of Public Health and Institute of Health and Environment, Seoul National University, Seoul, South Korea

* Correspondence to: Dr H. S. Park, Department of Family Medicine, University of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul 138-736, South Korea. Tel: +82-2-3010-3813; Fax: +82-2-3010-3815; E-mail: hyesoon{at}amc.seoul.kr

Background: We examined the association between the metabolic syndrome and cancer mortality in Koreans.

Materials and methods: This study included 42 336 men and 32 168 women aged ≥20 years who took health examination and were followed up for 5.6 years. Mortality data were analyzed according to the metabolic syndrome.

Results: The relative risk (RR) and 95% confidence interval (CI) of cancer mortality in subjects with metabolic syndrome compared with subjects without metabolic syndrome was 1.41 (1.08–1.84) after adjustment for possible confounding factors. The association is significant only among men [RR 1.52 (1.10–2.10)], but not among women. The RRs and 95% CIs for cancer deaths in subjects with elevated body mass index, blood pressure, fasting glucose, and triglycerides were 1.36 (1.07–1.71), 1.34 (1.07–1.69), 1.45 (1.14–1.86), and 1.60 (1.26–2.02) after mutual adjustment, respectively. Upon increasing the number of metabolic risk factors to 1, 2–3, and 4–5, the RRs and 95% CIs of death from cancer were 1.32 (0.83–1.48), 1.47 (1.10–1.96), and 2.42 (1.25–4.68), respectively, with a graded fashion (P for trend < 0.005).

Conclusion: Our results indicate that metabolic syndrome is a risk factor for cancer-related death in Korean adults. Prevention and management of the metabolic syndrome would be needed to reduce cancer mortality.

cancer mortality, Korean, metabolic risk factors, metabolic syndrome

Received for publication January 22, 2009. Revision received June 1, 2009. Accepted for publication June 3, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.